Erratum: inhibition of rhabdomyosarcoma cell and tumor growth by targeting specificity protein (sp) transcription factors.

Histone Deacetylase Inhibitors Inhibit Rhabdomyosarcoma by Reactive Oxygen Species-Dependent Targeting of Specificity Protein Transcription Factors.

Specificity protein (Sp) transcription factors and metformin regulate expression of the long non-coding RNA HULC.

Inhibition of tumor cell growth by retinoids.

FoxF1 and FoxF2 transcription factors synergistically promote rhabdomyosarcoma carcinogenesis by repressing transcription of p21Cip1 CDK inhibitor.

Mechanism of metformin-dependent inhibition of mammalian target of rapamycin (mTOR) and Ras activity in pancreatic cancer: role of specificity protein (Sp) transcription factors.

Inhibition of tumor growth and angiogenesis by SP-2, an anti-lectin, galactoside-binding soluble 3 binding protein (LGALS3BP) antibody.

10 impairs tumor growth through inhibition of angiogenesis.

Inhibition of metastatic tumor growth and metastasis via targeting metastatic breast cancer by chlorotoxin-modified liposomes.

Inhibition of Gastric Tumor Cell Growth Using Seed-targeting LNA as Specific, Long-lasting MicroRNA Inhibitors.

The Smac Mimetic BV6 Improves NK Cell-Mediated Killing of Rhabdomyosarcoma Cells by Simultaneously Targeting Tumor and Effector Cells.

Targeting activating mutations of EZH2 leads to potent cell growth inhibition in human melanoma by derepression of tumor suppressor genes.

Promoter specificity of basal transcription factors.

Targeting Transcription Factors in Cancer.

miR-98 suppresses tumor cell growth and metastasis by targeting IGF1R in oral squamous cell carcinoma.

Inhibition of lung tumor growth in nude mice by siRNACD31 targeting PECAM-1.

Inhibition of Ovarian Tumor Growth by Targeting the HU177 Cryptic Collagen Epitope.

Erratum to: miR-143 inhibits tumor progression by targeting FAM83F in esophageal squamous cell carcinoma.

TetraMabs: simultaneous targeting of four oncogenic receptor tyrosine kinases for tumor growth inhibition in heterogeneous tumor cell populations.

Inhibition of erythroid cell growth in irradiated mice by allogeneic lymphoid cells: specificity of the response.

Erratum: MiR-4295 promotes cell growth in bladder cancer by targeting BTG1.

Erratum to: Metabolomics of rhabdomyosarcoma cell during echovirus 30 infection.

Inhibition of miR-92b suppresses nonsmall cell lung cancer cells growth and motility by targeting RECK.

Zinc finger RNA-binding protein promotes non-small-cell carcinoma growth and tumor metastasis by targeting the Notch signaling pathway.

Reversal of inhibition of rat glomerular epithelial cell growth by growth factors.

Suggest Documents

Histone Deacetylase Inhibitors Inhibit Rhabdomyosarcoma by Reactive Oxygen Species-Dependent Targeting of Specificity Protein Transcription Factors.

Specificity protein (Sp) transcription factors and metformin regulate expression of the long non-coding RNA HULC.

Inhibition of tumor cell growth by retinoids.

FoxF1 and FoxF2 transcription factors synergistically promote rhabdomyosarcoma carcinogenesis by repressing transcription of p21Cip1 CDK inhibitor.

Mechanism of metformin-dependent inhibition of mammalian target of rapamycin (mTOR) and Ras activity in pancreatic cancer: role of specificity protein (Sp) transcription factors.

Inhibition of tumor growth and angiogenesis by SP-2, an anti-lectin, galactoside-binding soluble 3 binding protein (LGALS3BP) antibody.

10 impairs tumor growth through inhibition of angiogenesis.

Inhibition of metastatic tumor growth and metastasis via targeting metastatic breast cancer by chlorotoxin-modified liposomes.

Inhibition of Gastric Tumor Cell Growth Using Seed-targeting LNA as Specific, Long-lasting MicroRNA Inhibitors.

The Smac Mimetic BV6 Improves NK Cell-Mediated Killing of Rhabdomyosarcoma Cells by Simultaneously Targeting Tumor and Effector Cells.

Targeting activating mutations of EZH2 leads to potent cell growth inhibition in human melanoma by derepression of tumor suppressor genes.

Promoter specificity of basal transcription factors.

Targeting Transcription Factors in Cancer.

miR-98 suppresses tumor cell growth and metastasis by targeting IGF1R in oral squamous cell carcinoma.

Inhibition of lung tumor growth in nude mice by siRNACD31 targeting PECAM-1.

Inhibition of Ovarian Tumor Growth by Targeting the HU177 Cryptic Collagen Epitope.

Erratum to: miR-143 inhibits tumor progression by targeting FAM83F in esophageal squamous cell carcinoma.

TetraMabs: simultaneous targeting of four oncogenic receptor tyrosine kinases for tumor growth inhibition in heterogeneous tumor cell populations.

Inhibition of erythroid cell growth in irradiated mice by allogeneic lymphoid cells: specificity of the response.

Erratum: MiR-4295 promotes cell growth in bladder cancer by targeting BTG1.

Erratum to: Metabolomics of rhabdomyosarcoma cell during echovirus 30 infection.

Inhibition of miR-92b suppresses nonsmall cell lung cancer cells growth and motility by targeting RECK.

Zinc finger RNA-binding protein promotes non-small-cell carcinoma growth and tumor metastasis by targeting the Notch signaling pathway.

Reversal of inhibition of rat glomerular epithelial cell growth by growth factors.

Erratum: inhibition of rhabdomyosarcoma cell and tumor growth by targeting specificity protein (sp) transcription factors.

Recommend Documents

Follow Us